Companies / Exai Bio
Exai Bio
Palo Alto, United States
Exai Bio develops a next-generation RNA-based platform for early cancer detection using a simple blood draw and AI
Exai Bio, based in Palo Alto, United States, has 2 investors on file, among them Blue Venture Funds and Casdin Capital. Its site was last checked 7 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Blue Venture Funds
52 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (89%), Fintech (7%), Cybersecurity (2%).
See Blue Venture Funds' full profile · Who invests alongside it
More from Casdin Capital
109 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (83%), AI & Machine Learning (7%), Industrial & Manufacturing (3%).
See Casdin Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Exai Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Blue Venture Funds adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/exai.bio/investors
# also
GET /v1/companies/exai.bio
GET /v1/companies/exai.bio/news